A fungal prion is a prion that infects fungal hosts. Fungal prions are naturally occurring proteins that can switch between multiple, structurally distinct conformations, at least one of which is self-propagating and transmissible to other prions. This transmission of protein state represents an epigenetic phenomenon where information is encoded in the protein structure itself, instead of in nucleic acids. Several prion-forming proteins have been identified in fungi, primarily in the yeast Saccharomyces cerevisiae. These fungal prions are generally considered benign, and in some cases even confer a selectable advantage to the organism.
Fungal prions have provided a model for the understanding of disease-forming mammalian prions. Study of fungal prions has led to a characterisation of the sequence features and mechanisms that enable prion domains to switch between functional and amyloid-forming states.
Prions are formed by portable, transmissible prion domains that are often enriched in asparagine, glutamine, tyrosine and glycine residues. When a reporter protein is fused with a prion domain, it forms a chimeric protein that demonstrates the conformational switching that is characteristic of prions. Meanwhile, removing this prion domain prevents prionogenesis. This suggests that these prion domains are, in fact, portable and are the sole initiator of prionogenesis. This supports the protein-only hypothesis.
A recent study of candidate prion domains in S. cerevisiae found several specific sequence features that were common to proteins showing aggregation and self-templating properties. For example, proteins that aggregated had candidate prion domains that were more highly enriched in asparagine, while non-aggregating domains where more highly enriched in glutamine and charged peptides. There was also evidence that the spacing of charged peptides that prevent amyloid formation, such as proline, is important in prionogenesis. This discovery of sequence specificity was a departure from previous work that had suggested that the only determining factor in prionogenesis was the overall distribution of peptides.
The HET-s Prion of Podospora anserina
Podospora anserina is a filamentous fungus. Genetically compatible colonies of this fungus can merge and share cellular contents such as nutrients and cytoplasm. A natural system of protective "incompatibility" proteins exists to prevent promiscuous sharing between unrelated colonies. One such protein, called HET-s, adopts a prion-like form in order to function properly. The prion form of HET-s spreads rapidly throughout the cellular network of a colony and can convert the non-prion form of the protein to a prion state after compatible colonies have merged. However, when an incompatible colony tries to merge with a prion-containing colony, the prion causes the "invader" cells to die, ensuring that only related colonies obtain the benefit of sharing resources.
Prions of Yeast
[PSI+] & [URE3]
In 1965, Brian Cox, a geneticist working with the yeast Saccharomyces cerevisiae, described a genetic trait (termed [PSI+]) with an unusual pattern of inheritance. The initial discovery of [PSI+] was made in a strain auxotrophic for adenine due to a nonsense mutation. Despite many years of effort, Cox could not identify a conventional mutation that was responsible for the [PSI+] trait. In 1994, yeast geneticist Reed Wickner correctly hypothesized that [PSI+] as well as another mysterious heritable trait, [URE3], resulted from prion forms of the normal cellular proteins, Sup35p and Ure2p, respectively. The names of yeast prions are frequently placed within brackets to indicate that they are non-mendelian in their passage to progeny cells, much like plasmid and mitochondrial DNA.
Further investigation found that [PSI+] is the result of a self-propagating misfolded form of Sup35p (a 201 amino acid long protein), which is an important factor for translation termination during protein synthesis. In [PSI+] yeast cells the Sup35 protein forms filamentous aggregates known as amyloid. The amyloid conformation is self-propagating and represents the prion state. Amazingly distinct prion states exist for the Sup35 protein with distinct properties and these distinctions are self-propagating. Other prions also can form distinct different variants (or strains). It is believed that suppression of nonsense mutations in [PSI+] cells is due to a reduced amount of functional Sup35 because much of the protein is in the amyloid state. The Sup35 protein assembles into amyloid via an amino-terminal prion domain. The structure is based on the stacking of the prion domains in an in-register and parallel beta sheet conformation.
An important finding by Chernoff, in a collaboration between the Liebman and Lindquist laboratories, was that a protein chaperone was required for [PSI+] to be maintained. Because the only function of chaperones is to help proteins fold properly, this finding strongly supported Wickner's hypothesis that [PSI+] was a heritable protein state (i.e. a prion). Likewise, this finding also provided evidence for the general hypothesis that prions, including the originally proposed mammalian PrP prion, are heritable forms of protein. Because of the action of chaperones, especially Hsp104, proteins that code for [PSI+] and [URE3] can convert from non-prion to prion forms. For this reason, yeast prions are good models for studying factors like chaperones that affect protein aggregation. Also, the IPOD is the sub-cellular site to which amyloidogenic proteins are sequestered in yeast, and where prions like [PSI+] may undergo maturation. Thus, prions also serve as substrates to understand the intracellular processing of protein aggregates such as amyloid.
Laboratories commonly identify [PSI+] by growth of a strain auxotrophic for adenine on media lacking adenine, similar to that used by Cox et al. These strains cannot synthesize adenine due to a nonsense mutation in one of the enzymes involved in the biosynthetic pathway. When the strain is grown on yeast-extract/dextrose/peptone media (YPD), the blocked pathway results in buildup of a red-colored intermediate compound, which is exported from the cell due to its toxicity. Hence, color is an alternative method of identifying [PSI+] -- [PSI+] strains are white or pinkish in color, and [psi-] strains are red. A third method of identifying [PSI+] is by the presence of Sup35 in the pelleted fraction of cellular lysate.
When exposed to certain adverse conditions, in some genetic backgrounds [PSI+] cells actually fare better than their prion-free siblings; this finding suggests that the ability to adopt a [PSI+] prion form may result from positive evolutionary selection. It has been speculated that the ability to convert between prion-infected and prion-free forms acts as an evolutionary capacitor to enable yeast to quickly and reversibly adapt in variable environments. Nevertheless, Reed Wickner maintains that [URE3] and [PSI+] are diseases, although this claim has been challenged using theoretical population genetic models.
[PIN+] / [RNQ+]
The term [PIN+] was coined by Liebman and colleagues from Psi-INducibility, to describe a genetic requirement for the formation of the [PSI+] prion.. They showed that [PIN+] was required for the induction of most variants of the [PSI+] prion. Later they identified [PIN+] as the prion form of the RNQ1 protein   The more precise name [RNQ+] is now sometimes used because other factors or prions can also have a Psi-inducing phenotype.
A non-prion function of Rnq1 has not been definitively characterized. Though reasons for this are poorly understood, it is suggested that [PIN+] aggregates may act as "seeds" for the polymerization of [PSI+] and other prions. The basis of the [PIN+] prion is an amyloid form of Rnq1 arranged in in-register parallel beta sheets, like the amyloid form of Sup35. Due to similar amyloid structures, the [PIN+] prion may facilitate the formation of [PSI+] through a templating mechanism.
Two modified versions of Sup35 have been created that can induce PSI+ in the absence of [PIN+] when overexpressed. One version was created by digestion of the gene with the restriction enzyme Bal2, which results in a protein consisting of only the M and N portions of Sup35. The other is a fusion of Sup35NM with HPR, a human membrane receptor protein.
Prions act as an alternative form of non-Mendelian, phenotypic inheritance due to their self-templating ability. This makes prions a metastable, dominant mechanism for inheritance that relies solely on the conformation of the protein. Many proteins containing prion domains play a role in gene expression or RNA binding, which is how an alternative conformation can give rise to phenotypic variation. For example, the [psi-] state of Sup35 in yeast is a translation termination factor. When Sup35 undergoes a conformational change to the [PSI+] prion state, it forms amyloid fibrils and is sequestered, leading to more frequent stop codon read-through and the development of novel phenotypes. With over 20 prion-like domains identified in yeast, this gives rise to the opportunity for a significant amount of variation from a single proteome. It has been posited that this increased variation gives a selectable advantage to a population of genetically homogeneous yeast.
List of Characterized Prions
|Protein||Natural Host||Normal Function||Prion State||Prion Phenotype||Year Identified|
|Ure2p||Saccharomyces cerevisiae||Nitrogen catabolite repressor||[URE3]||Growth on poor nitrogen sources||1994|
|Sup35p||Saccharomyces cerevisiae||Translation termination factor||[PSI+]||Increased levels of nonsense suppression||1994|
|HET-S||Podospora anserina||Regulates heterokaryon incompatibility||[Het-s]||Heterokaryon formation between incompatible strains||1997|
|vacuolar protease B||Saccharomyces cerevisiae||death in stationary phase, failure in meiosis||[β]||failure to degrade cellular proteins under N starvation||2003|
|MAP kinases||Podospora anserina||increased pigment, slow growth||[C]||2006|
|Rnq1p||Saccharomyces cerevisiae||Protein template factor||[RNQ+],[PIN+]||Promotes aggregation of other prions||2000|
|Mca1*||Saccharomyces cerevisiae||Putative Yeast Caspase||[MCA+]||Unknown||2008|
|Swi1||Saccharomyces cerevisiae||Chromatin remodeling||[SWI+]||Poor growth on some carbon sources||2008|
|Cyc8||Saccharomyces cerevisiae||Transcriptional repressor||[OCT+]||Transcriptional derepression of multiple genes||2009|
|Mot3||Saccharomyces cerevisiae||Nuclear transcription factor||[MOT3+]||Transcriptional derepression of anaerobic genes||2009|
|Pma1+Std1 ||Saccharomyces cerevisiae||Pma1 = major plasma membrane proton pump, Std1=minor pump||[GAR+]||Resistant to glucose-associated repression||2009|
|Sfp1 ||Saccharomyces cerevisiae||Global transcriptional regulator||[ISP+]||Antisuppressor of certain sup35 mutations||2010|
|Mod5 ||Saccharomyces cerevisiae||[MOD+]||2012|
[*The original paper that proposed Mca1 is a prion was retracted ]
- Michelitsch MD, Weissman JS (2000). "A census of glutamine/asparagine-rich regions: implications for their conserved function and the prediction of novel prions". Proc Natl Acad Sci U S A. 97 (22): 11910–5. Bibcode:2000PNAS...9711910M. doi:10.1073/pnas.97.22.11910. JSTOR 123764. PMC 17268. PMID 11050225.
- Alberti S, Halfmann R, King O, Kapila A, Lindquist S (2009). "A Systematic Survey Identifies Prions and Illuminates Sequence Features of Prionogenic Proteins". Cell. 137 (1): 146–158. doi:10.1016/j.cell.2009.02.044. PMC 2683788. PMID 19345193.
- Coustou V, Deleu C, Saupe S, Begueret J (1997). "The protein product of the het-s heterokaryon incompatibility gene of the fungus Podospora anserina behaves as a prion analog". Proc Natl Acad Sci U S A. 94 (18): 9773–8. Bibcode:1997PNAS...94.9773C. doi:10.1073/pnas.94.18.9773. JSTOR 43101. PMC 23266. PMID 9275200.
- Greenwald J, Buhtz C, Ritter C, Kwiatkowski W, Choe S, Maddelein ML, Ness F, Cescau S, Soragni A, Leitz D, Saupe SJ, Riek R (2010). "The mechanism of prion inhibition by HET-S". Molecular Cell. 38 (6): 889–99. doi:10.1016/j.molcel.2010.05.019. PMC 3507513. PMID 20620958.
- Maddelein ML, Dos Reis S, Duvezin-Caubet S, Coulary-Salin B, Saupe SJ (2002). "Amyloid aggregates of the HET-s prion protein are infectious". Proc Natl Acad Sci U S A. 99 (11): 7402–7. Bibcode:2002PNAS...99.7402M. doi:10.1073/pnas.072199199. JSTOR 3058837. PMC 124243. PMID 12032295.
- Cox BS, Tuite MF, McLaughlin CS (1988). "The psi factor of yeast: a problem in inheritance". Yeast. 4 (3): 159–78. doi:10.1002/yea.320040302. PMID 3059716.
- Wickner RB (1994). "[URE3] as an altered URE2 protein: evidence for a prion analog in Saccharomyces cerevisiae". Science. 264 (5158): 566–9. Bibcode:1994Sci...264..566W. doi:10.1126/science.7909170. PMID 7909170.
- Paushkin SV, Kushnirov VV, Smirnov VN, Ter-Avanesyan MD (1996). "Propagation of the yeast prion-like PSI+ determinant is mediated by oligomerization of the SUP35-encoded polypeptide chain release factor". EMBO Journal. 15 (12): 3127–34. doi:10.1002/j.1460-2075.1996.tb00675.x. PMC 450255. PMID 8670813.
- Derkatch IL, Chernoff YO, Kushnirov VV, Inge-Vechtomov SG, Liebman SW (1996). "Genesis and variability of [PSI] prion factors in Saccharomyces cerevisiae". Genetics. 144 (4): 1375–86. PMC 1207691. PMID 8978027.
- Liebman SW, Chernoff YO (2012). "Prions in yeast". Genetics. 191 (4): 1041–72. doi:10.1534/genetics.111.137760. PMC 3415993. PMID 22879407.
- Shewmaker F, Wickner RB, Tycko R (December 2006). "Amyloid of the prion domain of Sup35p has an in-register parallel β-sheet structure". Proc Natl Acad Sci U S A. 103 (52): 19754–9. Bibcode:2006PNAS..10319754S. doi:10.1073/pnas.0609638103. JSTOR 30051383. PMC 1750918. PMID 17170131.
- Chernoff YO, Lindquist SL, Ono B, Inge-Vechtomov SG, Liebman SW (1995). "Role of the chaperone protein Hsp104 in propagation of the yeast prion-like factor [psi+]". Science. 268 (5212): 880–4. doi:10.1126/science.7754373. PMID 7754373.
- Tyedmers J, Treusch S, Dong J, McCaffery JM, Bevis B, Lindquist S (May 2010). "Prion induction involves an ancient system for the sequestration of aggregated proteins and heritable changes in prion fragmentation". Proc Natl Acad Sci U S A. 107 (19): 8633–8. Bibcode:2010PNAS..107.8633T. doi:10.1073/pnas.1003895107. JSTOR 25681468. PMC 2889312. PMID 20421488.
- True HL, Lindquist SL (2000). "A yeast prion provides a mechanism for genetic variation and phenotypic diversity". Nature. 407 (6803): 477–83. doi:10.1038/35035005. PMID 11028992.
- Lancaster AK, Bardill JP, True HL, Masel J (2010). "The Spontaneous Appearance Rate of the Yeast Prion [PSI+] and Its Implications for the Evolution of the Evolvability Properties of the [PSI+] System". Genetics. 184 (2): 393–400. doi:10.1534/genetics.109.110213. PMC 2828720. PMID 19917766.
- Nakayashiki T, Kurtzman CP, Edskes HK, Wickner RB (2005). "Yeast prions [URE3] and [PSI+] are diseases". Proc Natl Acad Sci U S A. 102 (30): 10575–80. Bibcode:2005PNAS..10210575N. doi:10.1073/pnas.0504882102. JSTOR 3376125. PMC 1180808. PMID 16024723.
- Griswold CK, Masel J (2009). "The Strength of Selection Against the Yeast Prion [PSI+]". Genetics. 181 (3): 1057–1063. doi:10.1534/genetics.108.100297. PMC 2651042. PMID 19153253.
- Derkatch IL, Bradley ME, Zhou P, Chernoff YO, Liebman SW (1997). "Genetic and environmental factors affecting the de novo appearance of the [PSI+] prion in Saccharomyces cerevisiae". Genetics. 147 (2): 507–19. PMC 1208174. PMID 9335589.
- Derkatch IL, Bradley ME, Hong JY, Liebman SW (2001). "Prions affect the appearance of other prions: the story of [PIN(+)]". Cell. 106 (2): 171–82. doi:10.1016/s0092-8674(01)00427-5. PMID 11511345.
- Sondheimer N, Lindquist S (2000). "Rnq1: an epigenetic modifier of protein function in yeast". Mol Cell. 5 (1): 163–72. doi:10.1016/s1097-2765(00)80412-8. PMID 10678178.
- Patel BK, Liebman SW (2007). ""Prion-proof" for [PIN+]: infection with in vitro-made amyloid aggregates of Rnq1p-(132-405) induces [PIN+]". J Mol Biol. 365 (3): 773–82. doi:10.1016/j.jmb.2006.10.069. PMC 2570204. PMID 17097676.
- Derkatch IL, Liebman SW (2007). "Prion-prion interactions". Prion. 1 (3): 161–9. doi:10.4161/pri.1.3.4837. PMC 2634589. PMID 19164893.
- Serio TR (2018). "[PIN+]ing down the mechanism of prion appearance". FEMS Yeast Res. 18 (3). doi:10.1093/femsyr/foy026. PMC 5889010. PMID 29718197.
- Chernoff YO (2001). "Mutation processes at the protein level: Is Lamarck back?". Mutation Research. 488 (1): 39–64. doi:10.1016/S1383-5742(00)00060-0. PMID 11223404.
- Wickner RB, Dyda F, Tycko R (February 2008). "Amyloid of Rnq1p, the basis of the PIN+ prion, has a parallel in-register beta-sheet structure". Proc Natl Acad Sci U S A. 105 (7): 2403–8. Bibcode:2008PNAS..105.2403W. doi:10.1073/pnas.0712032105. JSTOR 25451479. PMC 2268149. PMID 18268327.
- Derkatch IL, Bradley ME, Zhou P, Chernoff YO, Liebman SW (1997). "Genetic and Environmental Factors Affecting the de novo Appearance of the [PSI+] Prion in Saccharomyces cerevisiae". Genetics. 147 (2): 507–519. PMC 1208174. PMID 9335589.
- Halfmann R, Jarosz DF, Jones SK, Chang A, Lancaster AK, Lindquist S (2012). "Prions are a common mechanism for phenotypic inheritance in wild yeasts". Nature. 482 (7385): 363–U1507. Bibcode:2012Natur.482..363H. doi:10.1038/nature10875. PMC 3319070. PMID 22337056.
- Brown JC, Lindquist S (2009). "A heritable switch in carbon source utilization driven by an unusual yeast prion". Genes Dev. 23 (19): 2320–32. doi:10.1101/gad.1839109. PMC 2758746. PMID 19797769.
- Rogoza T, Goginashvili A, Rodionova S, Ivanov M, Viktorovskaya O, Rubel A, Volkov K, Mironova L (2010). "Non-Mendelian determinant [ISP+] in yeast is a nuclear-residing prion form of the global transcriptional regulator Sfp1". Proc Natl Acad Sci U S A. 107 (23): 10573–7. Bibcode:2010PNAS..10710573R. doi:10.1073/pnas.1005949107. JSTOR 25681824. PMC 2890785. PMID 20498075.
- Suzuki G, Shimazu N, Tanaka M (2012). "A Yeast Prion, Mod5, Promotes Acquired Drug Resistance and Cell Survival Under Environmental Stress". Science. 336 (6079): 355–359. Bibcode:2012Sci...336..355S. doi:10.1126/science.1219491. PMID 22517861.
- Nemecek J, Nakayashiki T, Wickner RB (2011). "Retraction for Nemecek et al., A prion of yeast metacaspase homolog (Mca1p) detected by a genetic screen". Proc Natl Acad Sci U S A. 108 (24): 10022. doi:10.1073/pnas.1107490108. PMC 3116407. PMID 21628591.